![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:5253Q GW Pharmaceuticals PLC 25 January 2002 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS AVS NO All relevant boxes should be completed in block capital letters. 1. Name of company 2. Name of director GW Pharmaceuticals PLC David Kirk 3. Please state whether notification indicates that it 4. Name of the registered holder(s) and, if more than one is in respect of holding of the shareholder named holder, the number of shares held by each of them (if in 2 above or in respect of a non-beneficial notified) interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of an non-beneficial interest see 23 below 5. Please state whether notification relates to a 6. Please state the nature of the transaction. For PEP person(s) connected with the director named in 2 transactions please indicate whether general/single above and identify the connected person(s) co PEP and if discretionary/non discretionary/non discretionary 7. Number of shares/ 8. Percentage of issued 9. Number of shares/amount of 10. Percentage of issued class amount of stock class stock disposed acquired 11. Class of security 12. Price per share 13. Date of transaction 14. Date company informed 15. Total holding following this notification 16. Total percentage holding of issued class following this notification If a director has been granted options by the company please complete the following boxes. 17. Date of grant 18. Period during which or date on which exercisable 23 January 2002 23 January 2005 19. Total amount paid (if any) for grant of the option 20. Description of shares or debentures involved: class, number n/a 2,450 Ordinary shares of 0.1p each 21. Exercise price (if fixed at time of grant) or 22. Total number od shares or debentures over which options indication that price is to be fixed at time of held following this notification exercise N/A Nil, See 23 below 23. Any additional information 24. Name of contact and telephone number for queries Free shares conditionally gifted under the rules of Jonathan Laughton the GW Pharmaceuticals All Employee Share Scheme, and held in trust by the GWP Trustee Company + 44 (0) 1980 557 000 Limited. The main condition is that the director must remain an employee of the Company for three years from the date of issue and the shares will be held by the trust until that time" 25. Name and signature of authorised company official responsible for making this notification Jonathan Laughton, Company Secretary Date of notification 25 January 2002 Company Announcements Office, Old Broad Street, London EC2N 1HP Facsimile: 020 7588 6057, 020 7334 8964/8965/8966 (PLEASE DO NOT POST) Enquiries: Company Monitoring; UK Listing Authority This information is provided by RNS The company news service from the London Stock Exchange
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions